---
title: "PROCEPT BioRobotics (PRCT) Gets a Buy from TD Cowen"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/286444153.md"
description: "TD Cowen analyst Josh Jennings has reiterated a Buy rating on PROCEPT BioRobotics (PRCT) with a price target of $34.00. Jennings, who focuses on the Healthcare sector, has an average return of -1.7% and a 40.68% success rate on his stock recommendations. Additionally, PROCEPT received a Buy rating from William Blair’s Brandon Vazquez, while Bank of America Securities maintained a Sell rating on the stock."
datetime: "2026-05-14T15:35:58.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/286444153.md)
  - [en](https://longbridge.com/en/news/286444153.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/286444153.md)
---

# PROCEPT BioRobotics (PRCT) Gets a Buy from TD Cowen

TD Cowen analyst Josh Jennings reiterated a Buy rating on PROCEPT BioRobotics today and set a price target of $34.00.

### Claim 55% Off TipRanks

-   Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
-   Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks

Jennings covers the Healthcare sector, focusing on stocks such as Boston Scientific, TransMedics Group, and Establishment Labs Holdings. According to TipRanks, Jennings has an average return of \-1.7% and a 40.68% success rate on recommended stocks.

In addition to TD Cowen, PROCEPT BioRobotics also received a Buy from William Blair’s Brandon Vazquez in a report issued on May 4. However, yesterday, Bank of America Securities maintained a Sell rating on PROCEPT BioRobotics (NASDAQ: PRCT).

### Related Stocks

- [PRCT.US](https://longbridge.com/en/quote/PRCT.US.md)
- [BIB.US](https://longbridge.com/en/quote/BIB.US.md)
- [LABU.US](https://longbridge.com/en/quote/LABU.US.md)
- [BBH.US](https://longbridge.com/en/quote/BBH.US.md)
- [IHI.US](https://longbridge.com/en/quote/IHI.US.md)
- [SBIO.US](https://longbridge.com/en/quote/SBIO.US.md)
- [PBE.US](https://longbridge.com/en/quote/PBE.US.md)
- [IBB.US](https://longbridge.com/en/quote/IBB.US.md)
- [XHE.US](https://longbridge.com/en/quote/XHE.US.md)
- [FBT.US](https://longbridge.com/en/quote/FBT.US.md)
- [XBI.US](https://longbridge.com/en/quote/XBI.US.md)
- [TD.US](https://longbridge.com/en/quote/TD.US.md)
- [BSX.US](https://longbridge.com/en/quote/BSX.US.md)
- [TMDX.US](https://longbridge.com/en/quote/TMDX.US.md)
- [ESTA.US](https://longbridge.com/en/quote/ESTA.US.md)
- [BAC.US](https://longbridge.com/en/quote/BAC.US.md)
- [BAC-Q.US](https://longbridge.com/en/quote/BAC-Q.US.md)
- [BML-L.US](https://longbridge.com/en/quote/BML-L.US.md)
- [BAC-L.US](https://longbridge.com/en/quote/BAC-L.US.md)
- [BAC-K.US](https://longbridge.com/en/quote/BAC-K.US.md)
- [BML-H.US](https://longbridge.com/en/quote/BML-H.US.md)
- [BAC-N.US](https://longbridge.com/en/quote/BAC-N.US.md)
- [BAC-E.US](https://longbridge.com/en/quote/BAC-E.US.md)
- [MER-K.US](https://longbridge.com/en/quote/MER-K.US.md)
- [BAC-O.US](https://longbridge.com/en/quote/BAC-O.US.md)
- [BML-G.US](https://longbridge.com/en/quote/BML-G.US.md)
- [BAC-M.US](https://longbridge.com/en/quote/BAC-M.US.md)
- [BAC-B.US](https://longbridge.com/en/quote/BAC-B.US.md)
- [BML-J.US](https://longbridge.com/en/quote/BML-J.US.md)
- [BAC-S.US](https://longbridge.com/en/quote/BAC-S.US.md)
- [BAC-P.US](https://longbridge.com/en/quote/BAC-P.US.md)
- [8648.JP](https://longbridge.com/en/quote/8648.JP.md)

## Related News & Research

- [Jefferies Sticks to Their Buy Rating for Dexcom (DXCM)](https://longbridge.com/en/news/286443716.md)
- [PROCEPT BioRobotics Corporation $PRCT Shares Sold by Comerica Bank](https://longbridge.com/en/news/286055323.md)
- [Resona Asset Management Co. Ltd. Cuts Position in Danaher Corporation $DHR](https://longbridge.com/en/news/286897088.md)
- [Analyst Reaffirms Buy on PAVmed, Citing Oncology Platform Momentum and Partnerships; Price Target Maintained at $16](https://longbridge.com/en/news/286945953.md)
- [Jenscare’s LuX-Valve Plus Shows Strong One-Year Results in Large Annulus Tricuspid Patients](https://longbridge.com/en/news/287144318.md)